Research and Developmeny Institute

Research and Development Institute (RDI) is a premier clinical research site network based in Southern California, specializing in the execution of Phase I-IV clinical trials for the pharmaceutical and biotechnology industries. Founded in 2008 and headquartered in Van Nuys, the institute operates multiple high-capacity research centers that provide comprehensive services across a wide array of therapeutic areas, including internal medicine, pediatrics, and neurology. RDI is distinguished by its robust patient recruitment capabilities, high-quality data management, and a track record of successful collaboration with global sponsors. In April 2022, RDI was acquired by Velocity Clinical Research, the world's largest integrated site organization, which integrated RDI's expertise and facilities into its global network to enhance clinical trial delivery. The company continues to operate as a key component of Velocity's Southern California presence, supporting the development of innovative therapies through rigorous clinical testing.